Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits

por Ray, K.J., Sibson, N.R., Kiltie, A.E.
Publicado 2015

Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]

por Ray, K.J., Sibson, N.R., Kiltie, A.E.
Publicado 2016

Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts

por Diggle, C. P., Bentley, J., Knowles, M. A., Kiltie, A. E.
Publicado 2005

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder

por Sak, S C, Barrett, J H, Paul, A B, Bishop, D T, Kiltie, A E
Publicado 2005

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

por Groselj, B, Sharma, N L, Hamdy, F C, Kerr, M, Kiltie, A E
Publicado 2013

Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters

por Eastham, A M, Marples, B, Kiltie, A E, Orton, C J, West, C M L
Publicado 1999

Radiation-induced micronuclei in human fibroblasts in relation to clonogenic radiosensitivity.

por O'Driscoll, M. C., Scott, D., Orton, C. J., Kiltie, A. E., Davidson, S. E., Hunter, R. D., West, C. M.
Publicado 1998

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

por Teo, M. T. W., Dyrskjøt, L., Nsengimana, J., Buchwald, C., Snowden, H., Morgan, J., Jensen, J. B., Knowles, M. A., Taylor, G., Barrett, J. H., Borre, M., Ørntoft, T. F., Bishop, D. T., Kiltie, A. E.
Publicado 2014

Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden

por Cazier, J.-B., Rao, S.R., McLean, C.M., Walker, A.L., Wright, B.J., Jaeger, E.E.M., Kartsonaki, C., Marsden, L., Yau, C., Camps, C., Kaisaki, P., Taylor, J., Catto, J.W., Tomlinson, I.P.M., Kiltie, A.E., Hamdy, F.C.
Publicado 2014

Corrigendum: Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden

por Cazier, J. -B., Rao, S. R., McLean, C. M., Walker, A. K., Wright, B. J., Jaeger, E. E. M., Kartsonaki, C., Marsden, L., Yau, C., Camps, C., Kaisaki, P., Taylor, J., Catto, J. W., Tomlinson, I. P. M., Kiltie, A. E., Hamdy, F. C.
Publicado 2014